Seclidemstat


CAS No. : 1423715-37-0

(Synonyms: SP-2577)

1423715-37-0
Price and Availability of CAS No. : 1423715-37-0
Size Price Stock
5mg $50 In-stock
10mg $80 In-stock
25mg $150 In-stock
50mg $250 In-stock
100mg $450 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-103713
M.Wt: 450.94
Formula: C20H23ClN4O4S
Purity: >98 %
Solubility: DMSO : 50 mg/mL (ultrasonic;warming;heat to 80°C)
Introduction of 1423715-37-0 :

Seclidemstat is a potent noncompetitive and reversible KDM1A (LSD1) inhibitor (Ki=31 nM, IC50=13 nM). Seclidemstat promotes antitumor immunity in switch/sucrose nonfermentable (SWI/SNF) complex mutated ovarian cancer, as well as inhibit virus production, viral DNA replication, and late gene expression. Seclidemstat can be used for the research of Ewing Sarcoma[1][2]. IC50 & Target: Ki: 31 nM (LSD1)[1]
IC50: 13 nM (LSD1)[1] In Vitro: Seclidemstat (72 hours) inhibits SWI/SNF-mutation-dependent tumor cell proliferation with IC50 ranging from 0.013 to 2.819 μM (COV434, BIN67, SCCOHT-1, TOV21G, SKOV3, A427, H522, A549, H1299, G401, G402, HCC15 cells)[2].
Seclidemstat (72 hours) promotes endogenous retroviruses (ERVs) expression and activation of IFNβ pathway in SCCOHT cell lines (SCCOHT-1, BIN67, and COV434 cells)[2].
Seclidemstat (3 μM) promotes PD-L1 expression in SCCOHT COV 434 pIND 20 BRG1-2.7 cell line[2].

Your information is safe with us.